Transforming growth factor β controls the directional migration of hepatocyte cohorts by modulating their adhesion to fibronectin

Molecular Biology of the Cell

Volumn 19, Issue 3, 2008, Pages 945-956

  Binamé, Fabien ^a   Lassus, Patrice ^a   Hibner, Urszula ^a  

^a INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; INTEGRIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ADHESION; CELL GROWTH; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; GENE EXPRESSION; LIVER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY;

ANIMALS; APOPTOSIS; CELL ADHESION; CELL COMMUNICATION; CELL LINE; CELL MEMBRANE; CELL MOVEMENT; CELL SURFACE EXTENSIONS; EPITHELIUM; FIBRONECTINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEPATOCYTES; HUMANS; INTEGRIN ALPHA5; MESODERM; MICE; PROTEIN SUBUNITS; RAC1 GTP-BINDING PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 41649118421     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E07-09-0967     Document Type: Article

References (69)

1. Antoine, B., Levrat, F., Vallet, V., Berbar, T., Cartier, N., Dubois, N., Briand, P., and Kahn, A. (1992). Gene expression in hepatocyte-like lines established by targeted carcinogenesis in transgenic mice. Exp. Cell Res. 200, 175-185.
2. Bachman, K. E., and Park, B. H. (2005). Dual nature of TGF-beta signaling: tumor suppressor vs. tumor promoter. Curr. Opin. Oncol. 17, 49-54.
3. Bastock, R., and Strutt, D. (2007). The planar polarity pathway promotes coordinated cell migration during Drosophila oogenesis. Development 134, 3055-3064.
4. Bates, R. C., Bellovin, D. I., Brown, C., Maynard, E., Wu, B., Kawakatsu, H., Sheppard, D., Oettgen, P., and Mercurio, A. M. (2005). Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J. Clin. Invest. 115, 339-347.
5. Bhowmick, N. A., Chytil, A., Plieth, D., Gorska, A. E., Dumont, N., Shappell, S., Washington, M. K., Neilson, E. G., and Moses, H. L. (2004). TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303, 848-851.
6. Bhowmick, N. A., Zent, R., Ghiassi, M., McDonnell, M., and Moses, H. L. (2001). Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity. J. Biol. Chem. 276, 46707-46713.
7. Bianco, A., Poukkula, M., Cliffe, A., Mathieu, J., Luque, C. M., Fulga, T. A., and Rorth, P. (2007). Two distinct modes of guidance signalling during collective migration of border cells. Nature 448, 362-365.
8. Bissell, D. M., and Maher, J. J. (2003). Hepatic fibrosis and cirrhosis. In: Hepatology, A Textbook of Liver Disease, vol. 1, ed. D. Zakim and T. D. Boyer, New York: Saunders, 395-416.
9. Bissell, D. M., Roulot, D., and George, J. (2001). Transforming growth factor beta and the liver. Hepatology 34, 859-867.
10. Bretscher, A., Edwards, K., and Fehon, R. G. (2002). ERM proteins and merlin: integrators at the cell cortex. Nat. Rev. Mol. Cell Biol. 3, 586-599.
11. Clark, J. B., Rice, L., Sadiq, T., Brittain, E., Song, L., Wang, J., and Gerber, D. A. (2005). Hepatic progenitor cell resistance to TGF-beta1's proliferative and apoptotic effects. Biochem. Biophys. Res. Commun. 329, 337-344.
12. Condeelis, J., Singer, R. H., and Segall, J. E. (2005). The great escape: when cancer cells hijack the genes for chemotaxis and motility. Annu. Rev. Cell Dev. Biol. 21, 695-718.
13. Cordenonsi, M., Dupont, S., Maretto, S., Insinga, A., Imbriano, C., and Piccolo, S. (2003). Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads. Cell 113, 301-314.
14. Couvelard, A., Bringuier, A. F., Dauge, M. C., Nejjari, M., Darai, E., Benifla, J. L., Feldmann, G., Henin, D., and Scoazec, J. Y. (1998). Expression of integrins during liver organogenesis in humans. Hepatology 27, 839-847.
15. Danen, E. H., van Rheenen, J., Franken, W., Huveneers, S., Sonneveld, P., Jalink, K., and Sonnenberg, A. (2005). Integrins control motile strategy through a Rho-cofilin pathway. J. Cell Biol. 169, 515-526.
16. Elliott, R. L., and Blobe, G. C. (2005). Role of transforming growth factor beta in human cancer. J. Clin Oncol 23, 2078-2093.
17. Fabregat, I., Sanchez, A., Alvarez, A. M., Nakamura, T., and Benito, M. (1996). Epidermal growth factor, but not hepatocyte growth factor, suppresses the apoptosis induced by transforming growth factor- beta in fetal hepatocytes in primary culture. FEBS Lett. 384, 14-18.
18. Farooqui, R., and Fenteany, G. (2005). Multiple rows of cells behind an epithelial wound edge extend cryptic lamellipodia to collectively drive cell-sheet movement. J. Cell Sci. 118, 51-63.
19. Friedl, P., Hegerfeldt, Y., and Tusch, M. (2004). Collective cell migration in morphogenesis and cancer. Int. J. Dev. Biol. 48, 441-449.
20. Friedl, P., and Wolf, K. (2003). Tumour-cell invasion and migration: diversity and escape mechanisms. Nat. Rev. Cancer 3, 362-374.
21. Gotzmann, J., Fischer, A. N., Zojer, M., Mikula, M., Proell, V., Huber, H., Jechlinger, M., Waerner, T., Weith, A., Beug, H., and Mikulits, W. (2006). A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes. Oncogene 25, 3170-3185.
22. Goumans, M. J., Valdimarsdottir, G., Itoh, S., Rosendahl, A., Sideras, P., and ten Dijke, P. (2002). Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J. 21, 1743-1753.
23. Gressner, A. M., Lahme, B., Mannherz, H. G., and Polzar, B. (1997). TGF-beta-mediated hepatocellular apoptosis by rat and human hepatoma cells and primary rat hepatocytes. J. Hepatol. 26, 1079-1092.
24. Grunert, S., Jechlinger, M., and Beug, H. (2003). Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat. Rev. Mol. Cell Biol. 4, 657-665.
25. Han, G., Lu, S. L., Li, A. G., He, W., Corless, C. L., Kulesz-Martin, M., and Wang, X. J. (2005). Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis. J. Clin. Invest. 115, 1714-1723.
26. Haouzi, D., Baghdiguian, S., Granier, G., Travo, P., Mangeat, P., and Hibner, U. (2005). Three-dimensional polarization sensitizes hepatocytes to Fas/CD95 apoptotic signalling. J. Cell Sci. 118, 2763-2773.
27. Heino, J., Ignotz, R. A., Hemler, M. E., Crouse, C., and Massague, J. (1989). Regulation of cell adhesion receptors by transforming growth factor-beta. Concomitant regulation of integrins that share a common beta 1 subunit. J. Biol. Chem. 264, 380-388.
28. Huber, M. A., Kraut, N., and Beug, H. (2005). Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell Biol. 17, 548-558.
29. Idobe, Y., Murawaki, Y., Kitamura, Y., and Kawasaki, H. (2003). Expression of transforming growth factor-beta 1 in hepatocellular carcinoma in comparison with the non-tumor tissue. Hepatogastroenterology 50, 54-59.
30. Janda, E., Lehmann, K., Killisch, I., Jechlinger, M., Herzig, M., Downward, J., Beug, H., and Grunert, S. (2002). Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J. Cell Biol. 156, 299-313.
31. Janda, E., Nevolo, M., Lehmann, K., Downward, J., Beug, H., and Grieco, M. (2006). Raf plus TGFbeta-dependent EMT is initiated by endocytosis and lysosomal degradation of E-cadherin. Oncogene. 25, 7117-7130.
32. Kamaraju, A. K., and Roberts, A. B. (2005). Role of Rho/ROCK and p38 MAP kinase pathways in transforming growth factor-beta-mediated Smad-dependent growth inhibition of human breast carcinoma cells in vivo. J. Biol. Chem. 280, 1024-1036.
33. Katuri, V., Tang, Y., Li, C., Jogunoori, W., Deng, C. X., Rashid, A., Sidawy, A. N., Evans, S., Reddy, E. P., Mishra, B., and Mishra, L. (2006). Critical interactions between TGF-beta signaling/ELF, and E-cadherin/beta- catenin mediated tumor suppression. Oncogene 25, 1871-1886.
34. Kupfer, A., Louvard, D., and Singer, S. J. (1982). Polarization of the Golgi apparatus and the microtubule-organizing center in cultured fibroblasts at the edge of an experimental wound. Proc. Natl. Acad. Sci. USA 79, 2603-2607.
35. Martinez-Hernandez, A., and Amenta, P. S. (1993). The hepatic extracellular matrix. I. Components and distribution in normal liver. Virchows Arch. A Pathol. Anat. Histopathol. 423, 1-11.
36. Massague, J., Blain, S. W., and Lo, R. S. (2000). TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103, 295-309.
37. Mettouchi, A., Klein, S., Guo, W., Lopez-Lago, M., Lemichez, E., Westwick, J. K., and Giancotti, F. G. (2001). Integrin-specific activation of Rac controls progression through the G(1) phase of the cell cycle. Mol. Cell 8, 115-127.
38. Michl, P. et al. (2005). CUTL1 is a target of TGF(beta) signaling that enhances cancer cell motility and invasiveness. Cancer Cell 7, 521-532.
39. Mishra, L., Shetty, K., Tang, Y., Stuart, A., and Byers, S. W. (2005). The role of TGF-beta and Wnt signaling in gastrointestinal stem cells and cancer. Oncogene 24, 5775-5789.
40. Nabeshima, K., Moriyama, T., Asada, Y., Komada, N., Inoue, T., Kataoka, H., Sumiyoshi, A., and Koono, M. (1995). Ultrastructural study of TPA-induced cell motility: human well-differentiated rectal adenocarcinoma cells move as coherent sheets via localized modulation of cell-cell adhesion. Clin. Exp. Metastasis 13, 499-508.
41. Nejjari, M., Hafdi, Z., Dumortier, J., Bringuier, A. F., Feldmann, G., and Scoazec, J. Y. (1999). alpha6beta1 integrin expression in hepatocarcinoma cells: regulation and role in cell adhesion and migration. Int. J. Cancer 83, 518-525.
42. Omelchenko, T., Vasiliev, J. M., Gelfand, I. M., Feder, H. H., and Bonder, E. M. (2003). Rho-dependent formation of epithelial "leader" cells during wound healing. Proc. Natl. Acad. Sci. USA 100, 10788-10793.
43. Pankov, R., Endo, Y., Even-Ram, S., Araki, M., Clark, K., Cukierman, E., Matsumoto, K., and Yamada, K. M. (2005). A Rac switch regulates random versus directionally persistent cell migration. J. Cell Biol. 170, 793-802.
44. Perlman, R., Schiemann, W. P., Brooks, M. W., Lodish, H. F., and Weinberg, R. A. (2001). TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nat. Cell Biol. 3, 708-714.
45. Pinkas, J., and Leder, P. (2002). MEK1 signaling mediates transformation and metastasis of EpH4 mammary epithelial cells independent of an epithelial to mesenchymal transition. Cancer Res. 62, 4781-4790.
46. Ridley, A. J. (2001). Rho GTPases and cell migration. J. Cell Sci. 114, 2713-2722.
47. Romero-Gallo, J. et al. (2005). Inactivation of TGF-beta signaling in hepatocytes results in an increased proliferative response after partial hepatectomy. Oncogene 24, 3028-3041.
48. Sahai, E., and Marshall, C. J. (2002). RHO-GTPases and cancer. Nat. Rev. Cancer 2, 133-142.
49. Sahai, E., and Marshall, C. J. (2003). Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat. Cell Biol. 5, 711-719.
50. Sanderson, N., Factor, V., Nagy, P., Kopp, J., Kondaiah, P., Wakefield, L., Roberts, A. B., Sporn, M. B., and Thorgeirsson, S. S. (1995). Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc. Natl. Acad. Sci. USA 92, 2572-2576.
51. Scoazec, J. Y., Flejou, J. F., D'Errico, A., Fiorentino, M., Zamparelli, A., Bringuier, A. F., Feldmann, G., and Grigioni, W. F. (1996). Fibrolamellar carcinoma of the liver: composition of the extracellular matrix and expression of cell-matrix and cell-cell adhesion molecules. Hepatology 24, 1128-1136.
52. Shimao, Y., Nabeshima, K., Inoue, T., and Koono, M. (1999). Role of fibroblasts in HGF/SF-induced cohort migration of human colorectal carcinoma cells: fibroblasts stimulate migration associated with increased fibronectin production via upregulated TGF-beta1. Int. J. Cancer 82, 449-458.
53. Siegel, P. M., and Massague, J. (2003). Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat. Rev. Cancer 3, 807-821.
54. Stamatoglou, S. C., Enrich, C., Manson, M. M., and Hughes, R. C. (1992). Temporal changes in the expression and distribution of adhesion molecules during liver development and regeneration. J. Cell Biol. 116, 1507-1515.
55. Stamatoglou, S. C., and Hughes, R. C. (1994). Cell adhesion molecules in liver function and pattern formation. FASEB J. 8, 420-427.
56. Strick-Marchand, H., and Weiss, M. C. (2002). Inducible differentiation and morphogenesis of bipotential liver cell lines from wild-type mouse embryos. Hepatology 36, 794-804.
57. Thiery, J. P. (2002). Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2, 442-454.
58. Thomas, D. A., and Massague, J. (2005). TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell 8, 369-380.
59. Thompson, E. W., Newgreen, D. F., and Tarin, D. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res 65, 5991-5995, 2005; discussion 5995.
60. Tian, Y. C., and Phillips, A. O. (2003). TGF-beta1-mediated inhibition of HK-2 cell migration. J. Am Soc. Nephrol. 14, 631-640.
61. Valdes, F., Murillo, M. M., Valverde, A. M., Herrera, B., Sanchez, A., Benito, M., Fernandez, M., and Fabregat, I. (2004). Transforming growth factor-beta activates both pro-apoptotic and survival signals in fetal rat hepatocytes. Exp. Cell Res. 292, 209-218.
62. Vasiliev, J. M. (2004). Cytoskeletal mechanisms responsible for invasive migration of neoplastic cells. Int. J. Dev. Biol. 48, 425-439.
63. Vega, S., Morales, A. V., Ocana, O. H., Valdes, F., Fabregat, I., and Nieto, M. A. (2004). Snail blocks the cell cycle and confers resistance to cell death. Genes Dev. 18, 1131-1143.
64. Wicki, A., Lehembre, F., Wick, N., Hantusch, B., Kerjaschki, D., and Christofori, G. (2006). Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell 9, 261-272.
65. Wu, J. C., Merlino, G., and Fausto, N. (1994). Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor alpha. Proc. Natl. Acad. Sci. USA 91, 674-678.
66. Xue, C., Plieth, D., Venkov, C., Xu, C., and Neilson, E. G. (2003). The gate-keeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Res. 63, 3386-3394.
67. Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., and Weinberg, R. A. (2004). Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117, 927-939.
68. Zambruno, G., Marchisio, P. C., Marconi, A., Vaschieri, C., Melchiori, A., Giannetti, A., and De Luca, M. (1995). Transforming growth factor-beta 1 modulates beta 1 and beta 5 integrin receptors and induces the de novo expression of the alpha v beta 6 heterodimer in normal human keratinocytes: implications for wound healing. J. Cell Biol. 129, 853-865.
69. Zicha, D., Genot, E., Dunn, G. A., and Kramer, I. M. (1999). TGFbeta1 induces a cell-cycle-dependent increase in motility of epithelial cells. J. Cell Sci. 112(Pt 4), 447-454.